PremiumCompany AnnouncementsAstraZeneca’s Tozorakimab Delivers Third Positive Phase III Result in COPD1d agoAZN
PremiumCompany AnnouncementsAstraZeneca Expands Real‑World Evidence for Acalabrutinib in CLL3d agoAZN
PremiumCompany AnnouncementsAstraZeneca’s Danicopan Korea Study: Real-World Data That Could Shape AZN’s Rare Disease Edge3d agoAZN